Identification of proteins in promastigote and amastigote-like Leishmania using an immunoproteomic approach

PLoS Neglected Tropical Diseases

Volumn 6, Issue 1, 2012, Pages

  Coelho, Vinicio T S ^a   Oliveira, Jamil S ^a   Valadares, Diogo G ^a   Chávez Fumagalli, Miguel A ^a   Duarte, Mariana C ^a   Lage, Paula S ^a   Soto, Manuel ^b   Santoro, Marcelo M ^a   Tavares, Carlos A P ^a   Fernandes, Ana Paula ^a   Coelho, Eduardo A F ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; PROTOZOAL PROTEIN;

AMASTIGOTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; ISOELETRIC FOCUSING; LEISHMANIA INFANTUM; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMASTIGOTE; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS; VISCERAL LEISHMANIASIS; ANIMAL; ANIMAL DISEASE; DOG DISEASE; GENE EXPRESSION REGULATION; GENETICS; LEISHMANIA; METABOLISM; PARASITOLOGY; PHYSIOLOGY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; DATABASES, PROTEIN; DOG DISEASES; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION; LEISHMANIA; LEISHMANIASIS, VISCERAL; PROTOZOAN PROTEINS; TANDEM MASS SPECTROMETRY;

EID: 84856573568     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001430     Document Type: Article

References (80)

1. Lainson R, Rangel EF, (2006) Lutzomyia longipalpis and the eco-epidemiology of American visceral leishmaniasis, with particular reference to Brazil: a review. Mem Inst Oswaldo Cruz 101: 117-118.
2. Alvar J, Canavate C, Molina R, Moreno J, Nieto J, (2004) Canine leishmaniasis. Adv Parasitol 57: 1-88.
3. Tavares CA, Fernandes AP, Melo MN, (2003) Molecular diagnosis of leishmaniasis. Expert Rev Mol Diagn 3: 657-667.
4. Barbiéri CL, (2006) Immunology of canine leishmaniasis. Parasite Immunol 28: 329-337.
5. Ciaramella P, Oliva G, Luna RD, Gradoni L, Ambrosio R, et al. (1997) A retrospective clinical study of canine leishmaniasis in 150 dogs naturally infected by Leishmania infantum. Vet Rec 141: 539-543.
6. Baneth G, Koutinas AF, Solano-Gallego L, Bourdeau P, Ferrer L, (2008) Canine leishmaniasis-new concepts and insights on an expanding zoonosis: part one. Trends Parasitol 24: 324-330.
7. Nieto CG, Navarrete I, Habela MA, Serrano F, Redondo E, (1992) Pathological changes in kidneys of dogs with natural Leishmania infection. Vet Parasitol 45: 33-47.
8. Garcia-Alonso M, Nieto CG, Blanco A, Requena JM, Alonso C, et al. (1996) Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features at the central nervous system. Parasite Immunol 18: 539-546.
9. Reed SG, (1996) Diagnosis of leishmaniasis. Clin Dermatol 14: 471-478.
10. Badaro R, Benson D, Eulalio MC, Freire M, Cunha S, et al. (1996) rK39: a cloned antigen of Leishmania infantum that predicts active visceral leishmaniasis. J Infect Dis 173: 758-761.
11. Ferreira WA, Mayrink W, Mares-Guia ML, Tavares CA, (2003) Detection and characterization of Leishmania antigens from an American cutaneous leishmaniasis vaccine for diagnosis of visceral leishmaniasis. Diagn Microbiol Infect Dis 45: 35-43.
12. Barbosa-de-Deus R, Mares-Guia ML, Nunes AZ, Costa KM, Junqueira RG, et al. (2002) Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis. Clin Diagn Lab Immunol 9: 1361-1366.
13. Carvalho FA, Charest H, Tavares CA, Matlashewski G, Valente EP, et al. (2002) Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagn Microbiol Infect Dis 43: 289-295.
14. Kubar J, Fragaki K, (2005) Recombinant DNA-derived Leishmania proteins: from the laboratory to the field. Lancet Infect Dis 5: 107-114.
15. Goto Y, Howard RF, Bhatia A, Trigo J, Nakatani M, et al. (2009) Distinct antigen recognition pattern during zoonotic visceral leishmaniasis in humans and dogs. Vet Parasitol 160: 215-220.
16. Porrozzi R, Da Costa MVS, Teva A, Falqueto A, Ferreira AL, et al. (2007) Comparative evaluation of enzyme-linked immunosorbent assays based on crude and recombinant leishmanial antigens for serodiagnosis of symptomatic and asymptomatic Leishmania infantum visceral infections in dogs. Clin Vaccine Immunol 14: 544-548.
17. Soto M, Requena JM, Quijada L, Alonso C, (1998) Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. J Clin Microbiol 36: 58-63.
18. Boarino A, Scalone A, Gradoni L, Ferroglio E, Vitale F, et al. (2005) Development of recombinant chimeric antigen expressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol 12: 647-653.
19. Coelho EA, Ramírez L, Costa MA, Coelho VT, Martins VT, et al. (2009) Specific serodiagnosis of canine visceral leishmaniasis using Leishmania species ribosomal protein extracts. Clin Vaccine Immunol 16: 1774-1780.
20. Gopfert U, Goehring N, Klein C, Ilg T, (1999) Proteophosphoglycans of Leishmania mexicana. Molecular cloning and characterization of the Leishmania mexicana ppg2 gene encoding the proteophosphoglycans aPPG and pPPG2 that are secreted by amastigotes and promastigote. J Biochem 344: 787-795.
21. Chenik M, Lakhal S, Ben Khalef N, Zribi L, Louzir H, et al. (2006) Approaches for the identification of potential excreted/secreted proteins of Leishmania major parasites. Parasitology 132: 493-509.
22. Paape D, Barrios-Lerena ME, Le Bihan T, Mackay L, Aebischer T, (2010) Gel free analysis of the proteome of intracellular Leishmania mexicana. Mol Biochem Parasitol 169: 108-114.
23. Drummelsmith J, Brochu V, Girard I, Messier N, Ouellette M, (2003) Proteome mapping of the protozoan parasite Leishmania and application to the study of drug targets and resistance mechanisms. Mol Cell Proteomics 2: 146-155.
24. El Fakhry Y, Ouellette M, Papadopoulou B, (2002) A proteomic approach to identify developmentally regulated proteins in Leishmania infantum. Proteomics 2: 1007-1017.
25. Bente M, Harder S, Wiesgigl M, Heukeshoven J, Gelhaus C, et al. (2003) Developmentally induced changes of the proteome in the protozoan parasite Leishmania donovani. Proteomics 3: 1811-1829.
26. Nugent PG, Karsani SA, Wait R, Tempero J, Smith DF, (2004) Proteomic analysis of Leishmania mexicana differentiation. Mol Biochem Parasit 136: 51-62.
27. Mc Nicoll F, Drummelsmith J, Muller M, Madore E, Boilard N, et al. (2006) A combined proteomic and transcriptomic approach to the study of stage differentiation in Leishmania infantum. Proteomics 6: 3567-3581.
28. Walker J, Vasquez JJ, Gomez MA, Drummelsmith J, Burchmore R, et al. (2006) Identification of developmentally-regulated proteins in Leishmania panamensis by proteome profiling of promastigote and axenic amastigotes. Mol Biochem Parasitol 147: 64-73.
29. Leifso K, Cohen-Freue G, Dogra N, Murray A, Mc Master WR, (2007) Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed. Mol Biochem Parasitol 152: 35-46.
30. Rosenzweig D, Smith D, Myler PJ, Olafson RW, Zilberstein D, (2008) Post-translational modification of cellular proteins during Leishmania donovani differentiation. Proteomics 8: 1843-1850.
31. Morales MA, Watanabe R, Laurent C, Lenormand P, Rousselle JC, et al. (2008) Phosphoproteomic analysis of Leishmania donovani pro-and amastigote stages. Proteomics 8: 350-363.
32. Brotherton MC, Racine G, Foucher AL, Drummelsmith J, Papadopoulou B, et al. (2010) Analysis of stage-specific expression of basic proteins in Leishmania infantum. J Proteome Res 9: 3842-3853.
33. Costa CHN, Peters NC, Maruyama SR, Brito EC Jr, Santos IKFM, (2011) Vaccines for the Leishmaniases: Proposals for a Research Agenda. The Working Group on Research Priorities for Development of Leishmaniasis Vaccines. PLoS Negl Trop Dis 5: e943.
34. Coelho EA, Tavares CA, Carvalho FA, Chaves KF, Teixeira KN, et al. (2003) Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection. Infect Immun 71: 3988-3994.
35. Doyle PS, Engel JC, Pimenta PFP, Silva PP, Dwyer DM, (1991) Leishmania donovani: long-term culture of axenic amastigotes at 37°C. Exp Parasitol 73: 326-334.
36. Lewis TS, Hunt JB, Aveline LD, Jonscher KR, Louie DF, et al. (2000) Identification of novel MAP kinase pathway signalling targets by functional proteomics and mass spectrometry. Mol Cell 6: 1343-1354.
37. Neuhoff V, Arold N, Taube D, Ehrhardt W, (1988) Improved staining of proteins in polyacrilamide gels including isoeletric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G-250 and R-250. Electrophoresis 9: 255-262.
38. Hong BX, Soong L, (2008) Identification and enzymatic activities of four protein disulfide isomerase (PDI) isoforms of Leishmania amazonensis. Parasitol Res 102: 437-446.
39. Santos CXC, Stolf BS, Takemoto PVA, Amanso AM, Lopes LR, et al. (2009) Protein disulfide isomerase (PDI) associates with NADPH oxidase and is required for phagocytosis of Leishmania infantum promastigote by macrophages. J Leukocyte Biol 86: 989-998.
40. Yurchenko V, Xuea Z, Sherryb B, Bukrinskyc M, (2008) Functional analysis of Leishmania major cyclophilin. Int J Parasitol 38: 633-639.
41. Luque-Ortega JR, Rivas L, (2007) Miltefosine (Hexadecylphosphocholine) inhibits cytochrome c oxidase in Leishmania donovani promastigote. Antim Agents and Chem 51: 1327-1332.
42. Dey D, Meneses C, Salotra P, Kamhawi S, Nakhasi HL, et al. (2010) Characterization of a Leishmania stage-specific mitochondrial membrane protein that enhances the activity of cytochrome c oxidase and its role in virulence. Mol Microbiol 77: 399-414.
43. Trujillo C, Ramírez R, Vélez ID, Berberich C, (1999) The humoral immune response to the kinetoplastid membrane protein-11 in patients with American Leishmaniasis and Chagas' disease: prevalence of IgG subclasses and mapping of epitopes. Immunol Letters 70: 203-209.
44. Iniesta V, Corraliza I, Carcelén J, Gordo LG, Fernández-Cotrina J, et al. (2008) Leishmania major infection in susceptible and resistant mice elicit a differential humoral response against a total soluble fraction and defined recombinant antigens of the parasite. Parasitol Res 102: 887-893.
45. Marcelain K, Colombo A, Molina MC, Ferreira L, Lorca M, et al. (2000) Development of an immunoenzymatic assay for the detection of human antibodies against Trypanosoma cruzi calreticulin, an immunodominant antigen. Acta Tropica 75: 291-300.
46. Basu R, Bhaumik S, Basu JM, Naskar, De T, et al. (2005) Responses in visceral leishmaniasis evidence for mixed Th1-and Th2-like synthase activity and IL-4 generation: that correlates with inducible nitric oxide and resistant strains of Leishmania donovani against both pentavalent antimonial-sensitive vaccination induces complete protection kinetoplastid membrane protein-11 DNA. J Immunol 174: 7160-7171.
47. Streit JA, Recker TJ, Donelson JE, Wilson ME, (2000) BCG expressing LCR1 of Leishmania infantum induces protective immunity in susceptible mice. Exp Parasit 94: 33-41.
48. Naula C, Parsons M, Mottram JC, (2005) Protein kinases as drug targets in trypanosomes and Leishmania. Biochimica et Biophysica Acta 1754: 151-159.
49. Yoffe Y, Zuberek J, Lerer A, Lewdorowicz M, Stepinski J, et al. (2006) Binding specificities and potential roles of isoforms of eukaryotic initiation factor 4E in Leishmania. Eukaryotic Cell 5: 1969-1979.
50. Johnson RE, Campbell-Bright S, Ralph H, Raasch Jo, Rodgers E, (2008) Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A). Int J Antimicrobial Agents 31: 581-592.
51. Siqueira-Neto JL, Song OR, Jeong-Hun HOS, Yang G, Nam J, et al. (2010) Antileishmanial high-throughput drug screening reveals drug candidates with new scaffolds. PLOS Negl Trop Dis 4: e675.
52. Aguilar-Be I, Zardo RS, Paraguai-de-Souza E, Borja-Cabrera P, Rosado-Vallado M, et al. (2005) Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis. Infect Immun 73: 812-819.
53. Iborra S, Parody N, Abánades DR, Bonay P, Prates D, et al. (2008) Vaccination with the Leishmania major ribosomal proteins plus CpG oligodeoxynucleotides induces protection against experimental cutaneous leishmaniasis in mice. Microbes and Infection 10: 1133-1141.
54. Chávez-Fumagalli MA, Costa MAF, Oliveira DM, Ramírez L, Costa LE, et al. (2010) Vaccination with the Leishmania infantum ribosomal proteins induces protection in BALB/c mice against Leishmania infantum and Leishmania amazonensis challenge. Microbes and Infection 12: 967-977.
55. Santarém N, Tomás A, Ouaissi A, Tavares J, Ferreira N, et al. (2005) Antibodies against a Leishmania infantum peroxiredoxin as a possible marker for diagnosis of visceral leishmaniasis and for monitoring the efficacy of treatment. Immunol Letters 101: 18-23.
56. Pateraki E, Portocala R, Labrousse H, Guesdon JL, (1983) Antiactin and antitubulin antibodies in canine visceral leishmaniasis. Infect Immun 42: 496-500.
57. Shapira M, Mc Ewen JG, Jaffe CL, (1988) Temperature effects on molecular processes which lead to stage differentiation in Leishmania. The EMBO J 7: 2895-2901.
58. Barhoumi M, Tanner NK, Banroques J, Linder P, Guizani I, (2006) Leishmania infantum LeIF protein is an ATP-dependent RNA helicase and an eIF4A-like factor that inhibits translation in yeast. FEBS Journal 273: 5086-5100.
59. Nasereddin A, Schweynoch C, Schonian G, Jaffe CL, (2010) Characterization of Leishmania (Leishmania) tropica axenic amastigotes. Acta Trop 113: 72-79.
60. Nandan D, Tran T, Trinh E, Silverman JM, Lopez M, (2007) Identification of Leishmania fructose-1,6-bisphosphate aldolase as a novel activator of host macrophage Src homology 2 domain containing protein tyrosine phosphatase SHP-1. Biochem Bioph Res Com 364: 601-607.
61. Jain R, Ghoshal A, Mandal C, Shaha C, (2010) Leishmania cell surface prohibitin: role in host-parasite interactions. Cel Microbiol 12: 432-452.
62. Castro H, Romao S, Gadelha FR, Tomás AM, (2008) Leishmania infantum: provision of reducing equivalents to the mitochondrial tryparedoxin/tryparedoxin peroxidase system. Exp Parasitol 120: 421-423.
63. Davis AJ, Perugini MA, Smith BJ, Stewart JD, Ilg T, et al. (2004) Properties of GDP-mannose pyrophosphorylase, a critical enzyme and drug target in Leishmania mexicana. J Biol Chem 279: 12462-12468.
64. Mc Carthy JS, Wieseman M, Tropea J, Kaslow D, Abraham D, et al. (2002) Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans. Infect Immun 70: 851-858.
65. Walque S, Opperdoes FR, Michels PAM, (1999) Cloning and characterization of Leishmania mexicana fructose-1,6-bisphosphate aldolase. Mol Biochem Parasitol 103: 279-283.
66. Sánchez-Cañete MP, Carvalho L, Pérez-Victoria FJ, Gamarro F, Castanys S, (2009) Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug. Antim Agents Chem 53: 1305-1313.
67. Poot J, Spreeuwenberg K, Sanderson SJ, Schijns VECJ, Mottram JC, et al. (2006) Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum. Vaccine 24: 2460-2468.
68. Koszalka GW, Krenitsky TA, (1986) 5′-Methylthioadenosine (MTA) phosphorylase from promastigote of Leishmania donovani. Adv Exp Med Biol 195: 559-563.
69. Bates PA, (1994) Complete developmental cycle of Leishmania mexicana in axenic culture. Parasitology 8: 1-9.
70. Paape D, Lippuner C, Schmid M, Ackermann R, Barrios-Llerena ME, et al. (2008) Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes. Mol Cell Proteomics 7: 1688-1701.
71. Bhatia A, Daifalla NS, Jen S, Badaro R, Reed SG, et al. (1999) Cloning, characterization and serological evaluation of K9 and K26: two related hydrophilic antigens of Leishmania chagasi. Mol Biochem Parasitol 102: 249-261.
72. Ferrer L, Solano-Gallego L, Arboix M, Arberola J, (2002) Evaluation of the specific immune response in dogs infected by Leishmania infantum. In: Thoday KL, Foil CS, Bond R, Editors. Adv Vet Dermatol, Blackwell Science Oxford 4: 92-99.
73. Reis AB, Giunchetti RC, Carrillo E, Martins-Filho OA, Moreno J, (2010) Immunity to Leishmania and the rational search for vaccines against canine leishmaniasis. Trends Parasitol 26: 341-349.
74. Dea-Ayuela MA, Rama-Iñiguez S, Bolás-Fernández F, (2006) Proteomic analysis of antigens from Leishmania infantum promastigote. Proteomics 6: 4187-4194.
75. Lynn MA, Mc Master WR, (2008) Leishmania: conserved evolution -diverse diseases. Trends Parasitol 24: 103-105.
76. Almeida R, Gilmartin BJ, Mc Canna SH, Norrish A, Ivens AC, et al. (2004) Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genome. Mol Biochem Parasitol 136: 87-100.
77. Cohen-Freue G, Holzer TR, Forney JD, McMaster WR, (2007) Global gene expression in Leishmania. Int J Parasitol 37: 1077-1086.
78. Gramiccia M, Gradoni L, (2005) The current status of zoonotic leishmaniasis and approaches to disease control. Int J Parasitol 35: 1169-1180.
79. Santarém RS, Cardoso L, Schallig H, Reed SG, Cordeiro-da-Silva A, (2010) Application of an improved enzyme-linked immunosorbent assay method for serological diagnosis of canine leishmaniasis. J Clin Microb 48: 1866-1874.
80. Almeida MAO, Jesus EEV, Sousa-Atta MLB, Alves LC, Berne MEA, et al. (2005) Antileishmanial antibody profile in dogs naturally infected with Leishmania chagasi. Vet Immunol Immunopathol 106: 151-158.